Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Introduction: Critically ill patients can develop hyperglycaemia even if they do not have diabetes. Intensive insulin therapy decreases morbidity and mortality rates in patients in a surgical intensive care unit (ICU) and decreases morbidity in patients in a medical ICU. The effect of this therapy on patients in a mixed medical/surgical ICU is unknown. Our goal was to assess whether the effect of intensive insulin therapy, compared with standard therapy, decreases morbidity and mortality in patients hospitalised in a mixed ICU. Methods: This is a prospective, randomised, non-blinded, single-centre clinical trial in a medical/surgical ICU. Patients were randomly assigned to receive either intensive insulin therapy to maintain glucose levels between 80 and 110 mg/dl (4.4 to 6.1 mmol/l) or standard insulin therapy to maintain glucose levels between 180 and 200 mg/dl (10 and 11.1 mmol/l). The primary end point was mortality at 28 days. Results: Over a period of 30 months, 504 patients were enrolled. The 28-day mortality rate was 32.4% (81 of 250) in the standard insulin therapy group and 36.6% (93 of 254) in the intensive insulin therapy group (Relative Risk [RR]: 1.1; 95% confidence interval [CI]: 0.85 to 1.42). The ICU mortality in the standard insulin therapy group was 31.2% (78 of 250) and 33.1% (84 of 254) in the intensive insulin therapy group (RR: 1.06; 95%CI: 0.82 to 1.36). There was no statistically significant reduction in the rate of ICU-acquired infections: 33.2% in the standard insulin therapy group compared with 27.17% in the intensive insulin therapy group (RR: 0.82; 95%CI: 0.63 to 1.07). The rate of hypoglycaemia (≤ 40 mg/dl) was 1.7% in the standard insulin therapy group and 8.5% in the intensive insulin therapy group (RR: 5.04; 95% CI: 1.20 to 21.12). Conclusions: IIT used to maintain glucose levels within normal limits did not reduce morbidity or mortality of patients admitted to a mixed medical/surgical ICU. Furthermore, this therapy increased the risk of hypoglycaemia. Trial Registration: clinicaltrials.gov Identifiers: 4374-04-13031; 094-2 in 000966421
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, intensified insulin therapy in critically-ill patients has been shown to be associated with a higher rate of severe hypoglycemic events than less aggressive glycemic control protocols.7–10”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [9]
In the citing paper
“Although a recent meta-analysis9 of 26 studies involving 13,567 patients reported no benefits in the general ICU population, it found a favorable effect of intensive glycemic control on mortality in surgical ICU patients (relative risk [RR], 0.63; confidence interval [CI], 0.44–0.91).”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“We registered every patient's age, sex, body mass index, diabetes history, type of diabetes treatment, previous infections, comorbidities, ICU admitting diagnosis, Acute Physiology and Chronic Health Evaluation (APACHE II) score [13], Sequential Organ Failure Assessment (SOFA) score [14] and Glasgow coma score.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 6×
“However, a decrease in mortality was observed in a subgroup of patients treated with intensive control for three or more days [6].”
BackgroundResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 1×
“Furthermore, the recently finished Volume Substitution and Insulin Therapy in Severe Sepsis trial, a randomised multicentre trial designed to assess the efficacy and safety of intensive insulin therapy in patients with severe sepsis and septic shock, was stopped early for safety reasons [16].”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Krinsley, J. S. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.992 · Cited by 1,223 · cited 1×
“Observational studies have suggested that strict glucose control is able to reduce hospital mortality in mixed medical/surgical ICUs [7,8], but other non-experimental studies in similar settings have not confirmed that the mean glucose level is an independent risk factor for ICU mortality.”
BackgroundMcCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170 · cited 1×
“Introduction Hyperglycaemia is frequently found in critically ill patients even in the absence of diabetes and it is associated with a poor prognosis [1-4].”
Background
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
“1 mmol/l]) was beneficial in a predominantly surgical ICU population (5), this target has been difficult to achieve in subsequent studies, including the recently published NICESUGAR study (14), without increasing the risk for severe hypoglycemia (12, 13,16,27,28).”
BackgroundDungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
Jacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Endocrine Practice · doi:10.4158/ep09102.ra · Cited by 518
“1 mmol/l]) was beneficial in a predominantly surgical ICU population (5), this target has been difficult to achieve in subsequent studies, including the recently published NICESUGAR study (14), without increasing the risk for severe hypoglycemia (12, 13,16,27,28).”
BackgroundToward Understanding Tight Glycemic Control in the ICU
Marik, P. E., & Preiser, J.-C. (2010) · Chest · doi:10.1378/chest.09-1737 · Cited by 365
Nyenwe, E. A., Jerkins, T. W., Umpierrez, G. E., & Kitabchi, A. E. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.010 · Cited by 343
“In a similar RCT, De La Rosa et al [74] reported that intensive glycemic control in a mixed medical-surgical ICU resulted in no decrease in morbidity or mortality, while”
BackgroundJoannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honore, P. M., Hoste, E., Ostermann, M., Oudemans-van Straaten, H. M., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 340
Qaseem, A., Humphrey, L. L., Chou, R., Snow, V., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00007 · Cited by 334
Tight Glycemic Control versus Standard Care after Pediatric Cardiac Surgery
Agus, M. S. D., Steil, G. M., Wypij, D., Costello, J. M., Laussen, P. C., Langer, M., Alexander, J. L., Scoppettuolo, L. A., Pigula, F. A., Charpie, J. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206044 · Cited by 274
Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review
Kansagara, D., Fu, R., Freeman, M., Wolf, F., & Helfand, M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00008 · Cited by 255
“…(38) Savioli et al, 2009 (39) Van den Berghe et al, 2001 (16) Grey and Perdrizet, 2004 (26) Kirdemir et al, 2008 (27) Arabi et al, 2008 (35) De La Rosa et al, 2008 (42) NICE-SUGAR, 2009 (17) Preiser et al, 2009 (41) Mackenzie et al, 2008 (40) Subtotal (I2 = 36.0%; P =…”
InfluentialEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Lin, J., Razak, N. N., Pretty, C. G., Le Compte, A., Docherty, P., Parente, J. D., Shaw, G. M., Hann, C. E., & Geoffrey Chase, J. (2011) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.12.008 · Cited by 215
Kavanagh, B. P., & McCowen, K. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001115 · Cited by 205
Tight Glycemic Control in Critically Ill Children
Agus, M. S. D., Wypij, D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V., Luckett, P. M., Alexander, J. L., Asaro, L. A., Curley, M. A. Q., Steil, G. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612348 · Cited by 204
Yamada, T., Shojima, N., Noma, H., Yamauchi, T., & Kadowaki, T. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4523-0 · Cited by 171
Perioperative glycaemic control for diabetic patients undergoing surgery
Buchleitner, A. M., Martínez-Alonso, M., Hernández, M., Solà, I., & Mauricio, D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007315.pub2 · Cited by 168
A.S.P.E.N. Clinical Guidelines: Nutrition Support of Adult Patients With Hyperglycemia
McMahon, M. M., Nystrom, E., Braunschweig, C., Miles, J., Compher, C., & the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112452001 · Cited by 164
“However, more recent large clinical trials failed to show benefit when such an aggressive target was achieved.(25,27-31,35) The largest randomized controlled trial that used primarily enteral nutrition at levels of energy intake that were appropriate actually found a higher mortality in patients treated with intensive…”
BackgroundHonarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006174 · Cited by 201
The NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3757-6 · Cited by 159
Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial
Kalfon, P., Giraudeau, B., Ichaï, C., Guerrini, A., Bréchot, N., Cinotti, R., Dequin, P., Riu-Poulenc, B., Montravers, P., Annane, D., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3189-0 · Cited by 174
Bench-to-bedside review: Glucose and stress conditions in the intensive care unit
Losser, M.-R., Damoisel, C., & Payen, D. M. (2010) · Critical Care · doi:10.1186/cc9100 · Cited by 169
Glycemic control in non-diabetic critically ill patients
Farrokhi, F., Smiley, D. D., & Umpierrez, G. E. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.05.004 · Cited by 158
Mifsud, S., Schembri, E. L., & Gruppetta, M. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.11.634 · Cited by 150
Chase, J. G., Compte, A. J. L., Suhaimi, F. M., Shaw, G. M., Lynn, A. M., Lin, J., Pretty, C. G., Razak, N. N. A., Parente, J. D., Hann, C. E., et al. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.11.006 · Cited by 141
International recommendations for glucose control in adult non diabetic critically ill patients
Ichai, C., Preiser, J.-C., (SFAR), F. T. S. F. D.-R., & Société de Réanimation de langue Française (SRLF) and the Experts group (2010) · Critical Care · doi:10.1186/cc9258 · Cited by 127
Peri-operative glycaemic control regimens for preventing surgical site infections in adults
Kao, L. S., Meeks, D. W., Moyer, V. A., & Lally, K. P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006806.pub2 · Cited by 126
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 148
Insulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
McDonnell, M. E., & Umpierrez, G. E. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.01.001 · Cited by 117
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 118
Holzinger, U., Warszawska, J. M., Kitzberger, R., Herkner, H., Metnitz, P., & Madl, C. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1471-y · Cited by 98
Glycaemic control in the perioperative period
Sebranek, J. J., Lugli, A. K., & Coursin, D. B. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet381 · Cited by 100
The optimal target for acute glycemic control in critically ill patients: A network meta-analysis.
Yatabe, T., Inoue, S., Sakaguchi, M., & Egi, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4558-2 · Cited by 95
The metrics of glycaemic control in critical care
Mackenzie, I. M. J., Whitehouse, T., & Nightingale, P. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2103-2 · Cited by 595
“Other investigators have not been able to replicate these results [11, 12].”
ResultGlycaemic control targets after traumatic brain injury: a systematic review and meta-analysis
Hermanides, J., Plummer, M. P., Finnis, M., Deane, A. M., Coles, J., & Menon, D. K. (2018) · Critical Care · doi:10.1186/s13054-017-1883-y · Cited by 100
“1 mmol/L [7, 8, 14, 24, 27], two studies for < 10 mmol/L [13, 26], one for 5.”
BackgroundInfluentialEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
Hall, R. N. (2012) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2012.09.013 · Cited by 97
Newton, C. A., Smiley, D., Bode, B. W., Kitabchi, A. E., Davidson, P. C., Jacobs, S., Steed, R. D., Stentz, F., Peng, L., Mulligan, P., et al. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.816 · Cited by 84
Metabolic and Nutrition Support in the Chronic Critical Illness Syndrome
Schulman, R. C., & Mechanick, J. I. (2012) · Respiratory Care · doi:10.4187/respcare.01620 · Cited by 97
Glucose Control in the ICU: A Continuing Story
Preiser, J., Chase, J. G., Hovorka, R., Joseph, J. I., Krinsley, J. S., Block, C. E. M. D., Desaive, T., Foubert, L. A., Kalfon, P., Pielmeier, U., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816648713 · Cited by 88
Damage Control for Intra-Abdominal Sepsis
Waibel, B. H., & Rotondo, M. F. (2012) · Surgical Clinics of North America · doi:10.1016/j.suc.2012.01.006 · Cited by 77
Damage control in trauma and abdominal sepsis
Waibel, B. H., & Rotondo, M. F. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181ec5cbe · Cited by 80
Umpierrez, G. E., Spiegelman, R., Zhao, V., Smiley, D. D., Pinzon, I., Griffith, D. P., Peng, L., Morris, T., Luo, M., Garcia, H., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182474bf9 · Cited by 77
“The observed mortality in both of our treatment groups was lower than previous observational studies in patients receiving PN (19, 32) and in large randomized controlled studies focused on BG control in critically ill patients (42-44).”
ResultGlucose Control and Mortality in Patients with Severe Traumatic Brain Injury
Griesdale, D. E. G., Tremblay, M.-H., McEwen, J., & Chittock, D. R. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9249-1 · Cited by 80
“Regardless of the setting, intensive insulin therapy has consistently been associated with an increased risk of severe hypoglycemia [8, 10–13, 16–19, 22–24].”
BackgroundNishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 85
Glucose homeostasis, nutrition and infections during critical illness
Ingels, C., Vanhorebeek, I., & den Berghe, G. V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.12.033 · Cited by 78
Untangling glycaemia and mortality in critical care
Uyttendaele, V., Dickson, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2017) · Critical Care · doi:10.1186/s13054-017-1725-y · Cited by 75
Glycemic Control in the Intensive Care Unit and during the Postoperative Period
Lena, D., Kalfon, P., Preiser, J., Ichaï, C., & Riou, B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3182078843 · Cited by 69
Marvin, M. R., Inzucchi, S. E., & Besterman, B. J. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0277 · Cited by 73
Shetty, S., Inzucchi, S. E., Goldberg, P. A., Cooper, D. A., Siegel, M. D., & Honiden, S. (2011) · Endocrine Practice · doi:10.4158/ep11260.or · Cited by 70
Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis
Yao, R.-Q., Ren, C., Wu, G., Zhu, Y., Xia, Z., & Yao, Y.-M. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.43447 · Cited by 70
“Rates of infection were documented in 19 trials[13, 42, 43, 45-47, 50, 52, 55-57, 59, 63, 65, 66, 75, 88, 89, 92].”
BackgroundInfluentialExpert consensus on the glycemic management of critically ill patients
Wu, Z., Liu, J., Zhang, D., Kang, K., Zuo, X., Xu, Q., Pan, A., Fang, W., Liu, F., Shang, Y., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.06.001 · Cited by 73
“[92] De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, et al.”
BackgroundManagement of hyperglycemia in hospitalized patients
Smiley, D. D., & Umpierrez, G. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05805.x · Cited by 68
Blood Glucose Control in the Intensive Care Unit: Benefits and Risks
Gunst, J., & den Berghe, G. V. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00702.x · Cited by 65
A systematic scoping review on the consequences of stress-related hyperglycaemia
Olariu, E., Pooley, N., Danel, A., Miret, M., & Preiser, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194952 · Cited by 68
Glucose management in critically ill adults and children
Mesotten, D., Preiser, J., & Kosiborod, M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00223-5 · Cited by 63
Dysglycemia and Glucose Control During Sepsis
Plummer, M. P., & Deane, A. M. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.010 · Cited by 68
Glucose control in critical care
Clain, J. M., Ramar, K., & Surani, S. R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i9.1082 · Cited by 65
Ling, Y., Li, X., & Gao, X. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.02.013 · Cited by 69
Inpatient Management of Diabetes and Hyperglycemia
Bogun, M. M., & Inzucchi, S. E. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.008 · Cited by 67
Liberal Glucose Control in ICU Patients With Diabetes: A Before-and-After Study*
Luethi, N., Cioccari, L., Biesenbach, P., Lucchetta, L., Kagaya, H., Morgan, R., Muzio, F. D., Presello, B., Gaafar, D., Hay, A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003087 · Cited by 61
Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient
Davidson, P., Kwiatkowski, C. A., & Wien, M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615591057 · Cited by 59
Friedrich, J. O., Chant, C., & Adhikari, N. K. (2010) · Critical Care · doi:10.1186/cc9240 · Cited by 53
Schultz, M. J., Harmsen, R. E., & Spronk, P. E. (2010) · Critical Care · doi:10.1186/cc8966 · Cited by 53
“Indeed, blood glucose levels could be checked using capillary whole blood samples, using less accurate glucose analyzers [ 3-7 ].”
BackgroundMethodInfluentialHyperglycemia and Acute Kidney Injury During the Perioperative Period
Mendez, C. E., Mesropian, P. J. D., Mathew, R. O., & Slawski, B. A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0701-7 · Cited by 59
“De La Rosa et al. 2008 [72] Medical-surgical ICU patients; >14 % surgical patients 504 RCT: intensive insulin therapy (glucose target 80–110 mg/dl) vs. standard insulin therapy (target 180–200 mg/dl) Renal impairment defined as peak SCr >2.5 mg/dl or peak BUN >60 mg/ dl; need for RRT (dialysis or…”
BackgroundInfluentialRelative Hypoglycemia in Diabetic Patients With Critical Illness
Kwan, T. N., Hessels, L., Marhoon, N., Robbins, R., Mårtensson, J., Ekinci, E. I., & Bellomo, R. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004213 · Cited by 53
Addressing hyperglycemia from hospital admission to discharge
Moghissi, E. S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903566822 · Cited by 51
Drincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0882-3 · Cited by 47
Safety and efficacy of continuous insulin infusion in noncritical care settings
Smiley, D. D., Rhee, M. K., Peng, L., Roediger, L., Mulligan, P., Satterwhite, L. G., Bowen, P., & Umpierrez, G. E. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.646 · Cited by 48
“Recent multicenter controlled trials, however, have not been able to reproduce these results and in fact, have reported an increased risk of severe hypoglycemia and mortality in ICU patients in association with tight glycemic control.(15,16,19) New glycemic targets call for more reasonable, achievable, and safer glyce…”
BackgroundInduced Hypothermia for Trauma: Current Research and Practice
Finkelstein, R. A., & Alam, H. B. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610366919 · Cited by 45
Wernly, B., Lichtenauer, M., Hoppe, U. C., & Jung, C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.24 · Cited by 47
“In a summary of five studies (15,18-21) comparing tight glucose control (blood glucose between 80–110 mg/dL) to control groups, an increased risk of death was reported for intensive insulin therapy and the control group showed better survival (OR 0.”
BackgroundUpdate on glucose in critical care
Lheureux, O., Prevedello, D., & Preiser, J. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.027 · Cited by 58
Glycemic control in the intensive care unit: A control systems perspective
Chase, J. G., Benyó, B. I., & Desaive, T. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.03.007 · Cited by 49
Reexamining the evidence for inpatient glucose control: New recommendations for glycemic targets
Moghissi, E. S. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100171 · Cited by 48
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Hua, J., Chen, G., Li, H., Fu, S., Zhang, L., Scott, M., & Li, Q. (2012) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2011.12.016 · Cited by 43
Glycemic Control and Organ Transplantation
Marvin, M. R., & Morton-Bailey, V. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300616 · Cited by 46
Glycemic Control in the Medical Intensive Care Unit
Kovalaske, M. A., & Gandhi, G. Y. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300613 · Cited by 47
A guideline for the use of variable rate intravenous insulin infusion in medical inpatients
George, S., Dale, J., Stanisstreet, D., & Care, T. J. B. D. S. (. F. I. (2015) · Diabetic Medicine · doi:10.1111/dme.12756 · Cited by 40
van Hooijdonk, R. T. M., Leopold, J. H., Winters, T., Binnekade, J. M., Juffermans, N. P., Horn, J., Fischer, J., van Dongen-Lases, E. C., & Schultz, M. J. (2015) · Critical Care · doi:10.1186/s13054-015-0757-4 · Cited by 46
“Continuous glucose monitoring (CGM) is suggested to increase practicalities and safety of insulin titration in ICU patients [1,4], in particular when targeting normal or near-normal blood glucose levels when hypoglycemic episodes can be expected [5-13].”
BackgroundCritical Care Management of Stress-Induced Hyperglycemia
Vanhorebeek, I., Gunst, J., & den Berghe, G. V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0988-2 · Cited by 43
NICE-SUGAR: the end of a sweet dream?
Preiser, J. (2009) · Critical Care · doi:10.1186/cc7790 · Cited by 40
Management of Hyperglycemia During the Perioperative Period
Pichardo-Lowden, A. R., & Gabbay, R. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0239-2 · Cited by 39
Surgery in the Patient with Endocrine Dysfunction
Kohl, B., & Schwartz, S. S. (2009) · Anesthesiology Clinics · doi:10.1016/j.anclin.2009.09.005 · Cited by 39
Lai, J., Li, Q., He, Y., Zou, S., Bai, X., & Rastogi, S. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.855409 · Cited by 60
How to Manage Perioperative Endocrine Insufficiency
Kohl, B., & Schwartz, S. S. (2010) · Anesthesiology Clinics · doi:10.1016/j.anclin.2010.01.003 · Cited by 38
Clinical benefits of tight glycaemic control: focus on the intensive care unit
Mesotten, D., & den Berghe, G. V. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.08.006 · Cited by 39
Optimal Glucose Management in the Perioperative Period
Evans, C. H., Lee, J., & Ruhlman, M. K. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.11.003 · Cited by 43
van Steen, S. C. J., Rijkenberg, S., Sechterberger, M. K., DeVries, J. H., & van der Voort, P. H. J. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1045 · Cited by 36
Accuracy of Blood Glucose Measurement and Blood Glucose Targets
Eerdekens, G.-J., Rex, S., & Mesotten, D. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905581 · Cited by 46
Insulin therapy in critically ill patients
Ellahham, S. H. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s14203 · Cited by 35
Hyperglycaemia in critically ill patients: the immune system’s sweet tooth
van Niekerk, G., Davis, T., & Engelbrecht, A. (2017) · Critical Care · doi:10.1186/s13054-017-1775-1 · Cited by 38
Impact of a computer-generated alert system on the quality of tight glycemic control
Meyfroidt, G., Wouters, P. J., Becker, W. D., Cottem, D., & den Berghe, G. V. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2159-7 · Cited by 31
Metadata
- Authors
- De La Rosa, G. D. C., Donado, J. H., Restrepo, A. H., Quintero, A. M., González, L. G., Saldarriaga, N. E., Bedoya, M., Toro, J. M., Velásquez, J. B., Valencia, J. C., Arango, C. M., Aleman, P. H., Vasquez, E. M., Chavarriaga, J. C., Yepes, A., Pulido, W., Cadavid, C. A., & GICI-HPTU, G. D. I. E. C. I.
- Affiliations
- Hospital Pablo Tobon Uribe (CO)
- Universidad Pontificia Bolivariana (CO)
- Universidad de Antioquia (CO)
- Venue
- Critical Care
- Published
- 2008-09-17
- Volume
- 12
- Issue
- 5
- Pages
- R120-R120
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2592751
- OpenAlex
- W2124463708
- Cited by
- 319
- References
- 19
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 4 · 2021: 12 · 2020: 12 · 2019: 14 · 2018: 15 · 2017: 21 · 2016: 22 · 2015: 18 · 2014: 13 · 2013: 19 · 2012: 34
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by)
- Funders
- European Society of Intensive Care Medicine
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, glycemic control, critically ill patients, ICU mortality, intensive care unit infections, hypoglycemia, hyperglycemia, insulin therapy, 28-day mortality, length of hospital stay, ICU length of stay, ICU admission rates, hospitalization rates, hospital costs
- MeSH terms
- Adult, Aged, Blood Glucose, Critical Care, Female, Hospitalization, Humans, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.